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During colitis, gut bacteria and bacterial components can traverse the mucus layer and contact host cells. In
this issue of Cell Host & Microbe, Hickey et al. (2015) show that sulfatases of Bacteroides thetaiotaomicron
are required for its outer membrane vesicles to transit to underlying host immune cells and cause colitis.Ulcerative colitis (UC) can result from an
exaggerated immune response to the
gut microbiota in genetically predisposed
individuals. In the healthy colon, the mi-
crobiota is well separated from the under-
lying epithelial cells by a thickmucus layer
composed of an attached, cross-linked
inner layer devoid of bacteria and a more
loosely arranged outer layer, which serves
as a source of nutrients for many mem-
bers of the gut microbiota. Studies have
shown that in UC, bacteria can cross the
mucus layer and contact host cells, lead-
ing to inflammation (Johansson et al.,
2014). The process by which bacteria
and bacterial components are able to
cross themucus layer in UC likely involves
both host mucus barrier defects (Corfield
et al., 1996; Johansson et al., 2014) and
microbial factors. In this issue of Cell
Host & Microbe, Hickey et al. (2015) use
an experimental mouse model of intesti-
nal inflammation (Kang et al., 2008) and
show that sulfatase enzymes of the gut
symbiont B. thetaiotaomicron are neces-
sary for inflammation by this organism
as they allow its outer membrane vesicles
(OMVs) to cross the mucus layer and con-
tact host immune cells.
The investigators use dnKO mice,
which are defective in both TGFbRII and
IL-10R2 signaling and spontaneously
develop intestinal inflammation resem-
bling fulminant human UC (Kang et al.,
2008). It was previously established that
inflammation in this animal model requires
both a microbial component, as antibiotic
treatment significantly diminished dis-
ease, and production of pro-inflammatory
cytokines, as disease was also amelio-
rated by administration of antibodies to
the cytokines IFNg and TNFa (Kang
et al., 2008). In dnKO mice pretreated
with antibiotics to abrogate disease, sub-540 Cell Host & Microbe 17, May 13, 2015 ª2sequent administration of particular mem-
bers of the mouse microbiota resulted
in inflammation similar to that mediated
by the complete microbiota (Bloom
et al., 2011). One such bacterial member
was B. thetaiotaomicron. The current
study sought to identify factors of
B. thetaiotaomicron necessary to trigger
inflammation in the dnKO mouse with an
emphasis on how B. thetaiotaomicron or
its products cross themucus layer to con-
tact underlying host cells.
Hickey et al. (2015) used a monoclonal
antibody (mAb) reactive to an abundant
surface protein of B. thetaiotaomicron
to track the bacteria in vivo. This mAb
was also found to react with OMVs
of B. thetaiotaomicron and labeled
OMVs from the feces of antibiotic-
treated dnKO mice gavaged with
B. thetaiotaomicron, demonstrating that
OMVs are synthesized in vivo in this
mouse model. Importantly, this mAb also
labeled bacterial particles, likely OMVs,
but not whole bacteria, in the mesen-
chymal cells around the crypt base in
the colon of antibiotic-treated dnKO
mice gavaged with B. thetaiotaomicron,
but not of similarly treated control
mice. These data demonstrate that
B. thetaiotaomicron molecules, present
in OMVs, localize below the epithelial
layer in dnKO mice.
The study next turned to the analysis
of products of B. thetaiotoaomicron
that contribute to this localization. The
B. thetaiotaomicron genome was previ-
ously shown to encode 28 predicted
sulfatases, which depend on a single
anaerobic sulfatase-maturating enzyme
(anSME) for their activation (Benjdia et al.,
2011). Deletion of the anSME encoding
gene results in a mutant that lacks sulfa-
tase activity (Benjdia et al., 2011). Based015 Elsevier Inc.on the fact that sulfatases are involved in
the digestion of mucus, which contain
sulfatedglycans, the involvement of bacte-
rial sulfatases in the inflammatory process
was analyzed. The investigators first
demonstrated that B. thetaiotaomicron
OMVs contain sulfatase activity. In
addition, they found that the DanSME
mutant does not trigger inflammation in
dnKO mice, despite colonizing the mice
to an equivalent level as wild-type
B. thetaiotaomicron. The prediction was
that the DanSME mutant fails to cause
inflammation because the sulfatases are
necessary for bacterial OMVs to cross the
mucus layer to activate the immune cells
underlying the epithelium. Indeed, colonic
macrophages isolated from antibiotic-
treated dnKO mice gavaged with wild-
type B. thetaiotaomicron had significantly
elevated mRNA for pro-inflammatory
modulators (Ptgs-2, TNFa, and IL-1b)
compared to mice gavaged with the
DanSME mutant. They further showed
that this difference is likely due to differen-
tial localization of B. thetaiotaomicron
sulfatase containing OMVs, compared to
OMVs from DanSME, rather than an
inability of products of DanSME OMVs to
activate macrophages, as OMVs of both
isogenic strains equally activated bone-
marrow-derived macrophages in vitro.
Finally, double immunofluorescence label-
ing of the colonic sections of dnKO mice
gavaged with B. thetaiotaomicron showed
that immune cells, consistent with macro-
phages, internalized B. thetaiotaomicron
OMVs.
The B. thetaiotaomicron strain used in
this study is the well-studied type strain
for which the sulfatases have been
demonstrated to contribute to bacterial
fitness in the intestines of healthy mice,
especially under conditions where the
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must forage on host glycans (Benjdia
et al., 2011). Removal of the sulfate group
from the glycans of sulfated mucins and
glycosaminoglycans allows the bacteria
to hydrolyze the glycans for use as a
source of nutrients. As all human gut Bac-
teroidales previously analyzed contain
genes encoding sulfatases as well as an
ortholog of anSME (Benjdia et al., 2011),
it is possible that the sulfatases of other
species of this order of abundant gut
bacteria may be important for inducing
intestinal inflammation in this and possibly
other models of colitis. In addition, OMVs
of Bacteroides species have been shown
to mediate important interactions with
the host (Shen et al., 2012; Stentz et al.,
2014), including protection from disease
(Shen et al., 2012), and to mediate both
beneficial and competitive interactions
with other bacterial members of the mi-
crobiota (Chatzidaki-Livanis et al., 2014;
Rakoff-Nahoum et al., 2014). Therefore,
OMVs that mediate normal microbe-
microbe and beneficial microbe-host
processes in the healthy gut are also the
vehicles that mediate disease in this
mouse model of colitis.The major conclusion of the study is
that sulfatases of B. thetaiotaomicron
allow OMVs to cross the mucus layer
of dnKO mice and contact underlying
host immune cells, which are more
potently activated in the dnKO mouse
compared to macrophages from wild-
type mice, leading to inflammation.
This raises the important question of
whether Bacteroides sulfatases may
play a role in human colitis. As the
colonic mucins in some UC patients
have been shown to contain less sulfate
than control individuals (Corfield et al.,
1996), Bacteroides sulfatases may
further desulfate mucins in UC patients,
potentially augmenting the ability of
bacteria or bacterial OMVs to contact
immune cells and exacerbate disease.
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Circadian rhythm involves diurnal oscillations in biological processes. In this issue of Cell Host & Microbe,
Leone et al. (2015) show that the gut microbiota influences the circadian clock and undergoes circadian
oscillations. Microbiota-produced metabolites change with host diet and may affect circadian rhythm,
highlighting functional links between diet and physiology.We are increasingly aware that many
aspects of our health—metabolic, immu-
nological, and even behavioral—are influ-
enced by the trillions of microorganisms
that populate our bodies (Gareau, 2014;
Hooper et al., 2012). This suggests the
possibility that manipulation of our resi-
dent bacteria, or microbiota, could beutilized therapeutically for a range of
health conditions. Such manipulations,
potentially in the form of fecal transplant
or the ingestion of specific probiotics,
could provide non-invasive and cost-
effective treatments for conditions such
as autoimmune disease and obesity.
To maximally exploit the host-bacteriainteraction to our benefit, we need to
understand the mechanisms by which
the microbiota influence specific aspects
of host physiology. The diversity of host
physiologies affected by the microbiota
combined with the diversity of microbes
and microbial by-products create a com-
plex and challenging scientific landscape.17, May 13, 2015 ª2015 Elsevier Inc. 541
